Description
A hybrid of selenium and an NSAID that has been shown to reduce the viability of different cancer cell lines, particularly colorectal cancer (CRC) cells (IC50 = 3.4 µM); inhibits the cell cycle in G1 and G2/M phases and induces apoptosis by activating caspase 3/7 and PARP cleavage
Formal name: selenocyanic acid, 2-[[2-(acetyloxy)benzoyl]amino]ethyl ester
Synonyms: Selenium-acetylsalicylic Acid
Molecular weight: 311.2
CAS: 1850293-95-6
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals||Research Area|Cancer|Cell Cycle|G1||Research Area|Cancer|Cell Cycle|G2/M||Research Area|Cancer|Cell Death|Apoptosis||Research Area|Immunology & Inflammation||Research Area|Lipid Biochemistry|Cyclooxygenase Pathway